International Patent: (S,E)-N-(1-CYCLOPROPYL-3-(METHYLSULFONYL)ALLYL)-2-(1,1-DIFLUOROETHYL)-4-PHENOXYPYRIMIDINE-5-CARBOXAMIDE FOR TREATING CANCER

GENEVA, Oct. 5 -- VIVIDION THERAPEUTICS, INC. filed a patent application (US2026/020548) for “(S,E)-N-(1-CYCLOPROPYL-3-(METHYLSULFONYL)ALLYL)-2-(1,1-DIFLUOROETHYL)-4-PHENOXYPYRIMIDINE-5-CARBOXAMIDE FOR TREATING CANCER”. With publication no. WO/2026/206950, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/505

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....